Nutra Pharma Corp (NPHC) stock
NPHCOTCMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
$0.00+0.00 (0.00%)
Close on Oct 19, 2026Market cap $806.69KP/E –Yield –
Nutra Pharma total assets
Total assets on the balance sheet at the end of each period.
Nutra Pharma's total assets was $622.86K at Jun 30, 2026. For fiscal 2025 it was $622.60K, up 3.9% from the year before. Over ten years it grew 4.9% a year on average. The highest annual figure on record is $780.02K in fiscal 2021.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $622.60K | +3.9% |
| FY2024 | Dec 31, 2024 | $599.50K | -6.4% |
| FY2023 | Dec 31, 2023 | $640.40K | -15.2% |
| FY2022 | Dec 31, 2022 | $754.91K | -3.2% |
| FY2021 | Dec 31, 2021 | $780.02K | +158.5% |
| FY2020 | Dec 31, 2020 | $301.79K | -11.2% |
| FY2019 | Dec 31, 2019 | $339.83K | +140.3% |
| FY2018 | Dec 31, 2018 | $141.42K | -63.7% |
| FY2017 | Dec 31, 2017 | $389.57K | +81.8% |
| FY2016 | Dec 31, 2016 | $214.26K | -44.7% |
| FY2015 | Dec 31, 2015 | $387.64K | +0.1% |
| FY2014 | Dec 31, 2014 | $387.26K | +199.4% |
| FY2013 | Dec 31, 2013 | $129.36K | -57.3% |
| FY2012 | Dec 31, 2012 | $302.88K | +32.1% |
| FY2011 | Dec 31, 2011 | $229.31K | -69.6% |
| FY2010 | Dec 31, 2010 | $753.43K | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $622.86K | -27.5% |
| Q1 FY2026 | Mar 31, 2026 | $616.52K | -20.5% |
| Q4 FY2025 | Dec 31, 2025 | $622.60K | +3.9% |
| Q3 FY2025 | Sep 30, 2025 | $709.85K | +27.0% |
| Q2 FY2025 | Jun 30, 2025 | $859.07K | +36.2% |
| Q1 FY2025 | Mar 31, 2025 | $775.18K | +24.9% |
| Q4 FY2024 | Dec 31, 2024 | $599.50K | -6.4% |
| Q3 FY2024 | Sep 30, 2024 | $558.84K | -21.4% |
| Q2 FY2024 | Jun 30, 2024 | $630.97K | -15.7% |
| Q1 FY2024 | Mar 31, 2024 | $620.75K | -14.4% |
| Q4 FY2023 | Dec 31, 2023 | $640.40K | -15.2% |
| Q3 FY2023 | Sep 30, 2023 | $711.34K | +3.0% |
| Q2 FY2023 | Jun 30, 2023 | $748.18K | -1.1% |
| Q1 FY2023 | Mar 31, 2023 | $724.88K | -6.6% |
| Q4 FY2022 | Dec 31, 2022 | $754.91K | -3.2% |
| Q3 FY2022 | Sep 30, 2022 | $690.66K | -17.3% |
| Q2 FY2022 | Jun 30, 2022 | $756.78K | +16.5% |
| Q1 FY2022 | Mar 31, 2022 | $775.84K | +78.4% |
| Q4 FY2021 | Dec 31, 2021 | $780.02K | +158.5% |
| Q3 FY2021 | Sep 30, 2021 | $835.25K | +176.9% |
| Q2 FY2021 | Jun 30, 2021 | $649.64K | +79.7% |
| Q1 FY2021 | Mar 31, 2021 | $434.90K | +24.6% |
| Q4 FY2020 | Dec 31, 2020 | $301.79K | -11.2% |
| Q3 FY2020 | Sep 30, 2020 | $301.59K | -18.6% |
| Q2 FY2020 | Jun 30, 2020 | $361.52K | -27.5% |
| Q1 FY2020 | Mar 31, 2020 | $348.92K | -9.2% |
| Q4 FY2019 | Dec 31, 2019 | $339.83K | +140.3% |
| Q3 FY2019 | Sep 30, 2019 | $370.39K | +47.1% |
| Q2 FY2019 | Jun 30, 2019 | $498.45K | -17.0% |
| Q1 FY2019 | Mar 31, 2019 | $384.31K | -19.2% |
| Q4 FY2018 | Dec 31, 2018 | $141.42K | -63.7% |
| Q3 FY2018 | Sep 30, 2018 | $251.76K | +83.9% |
| Q2 FY2018 | Jun 30, 2018 | $600.89K | +204.9% |
| Q1 FY2018 | Mar 31, 2018 | $475.69K | +122.0% |
| Q4 FY2017 | Dec 31, 2017 | $389.57K | +34.8% |
| Q3 FY2017 | Sep 30, 2017 | $136.94K | -52.3% |
| Q1 FY2017 | Mar 31, 2017 | $197.10K | – |
| Q4 FY2016 | Dec 31, 2016 | $214.26K | – |
| Q2 FY2016 | Jun 30, 2016 | $288.99K | – |
| Q1 FY2016 | Mar 31, 2016 | $286.84K | – |
See a number that looks wrong?